Pharmaceutical News

RSS

Study reveals three effective treatments to stop epilepsy seizures

There are effective treatments to stop life-threatening epilepsy seizures when the initial treatment has failed, a sweeping new study reveals.

3 Dec 2019

New HIV drug combo rolled out in South Africa

South Africa has started distribution of the new anti-retroviral pill that combines three drugs to combat the HIV menace. The distribution began Sunday 1st of December 2019, to mark the World AIDS Day.

2 Dec 2019

Painful endometriosis symptoms could be reduced with a cancer drug

The painful symptoms of endometriosis - a chronic condition which affects millions of women - could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

2 Dec 2019

New treatment could make passing kidney stones faster and less painful

Every year, more than half a million Americans visit the emergency room for kidney stone problems. In most cases, the stones eventually pass out of the body on their own, but the process can be excruciatingly painful.

2 Dec 2019

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

2 Dec 2019

New medicine could reduce number of infants dying from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

New medicine could reduce number of infant deaths from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

Comparative study finds three anti-seizure drugs to be equally safe and effective

A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective.

27 Nov 2019

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

27 Nov 2019

Some antiarrhythmic medications for AFib less effective in obese patients

Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity and AFib, the underlying mechanism of how obesity contributes to the heart arrhythmia is still unknown.

27 Nov 2019

Geospatial model helps compare costs of different anticoagulant therapies

Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral anticoagulants can be a more cost-effective alternative than traditional warfarin therapy when the patient's place of residence is taken into consideration.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.

26 Nov 2019

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. However, it has a completely different effect on the heart, as has now been discovered by a team of researchers at the University of Zurich.

26 Nov 2019